← Leaderboards
Craig C Porter
University Of Iowa
$22,028
Attributed
$22,028
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$22,028 · 2
By mechanism
M01$22,028 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Ronald G Strauss$2,442,597
- Kevin P. Campbell$16,898,890
- Lyndsay Anne Harshman$2,266,374
- William G Haynes$5,096,085
- Barry London$19,559,318
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationAdolescence (12-20)Beta Antiadrenergic AgentCardiovascular Disorder ChemotherapyChemopreventionChild (0-11)ChlorothiazideClinical ResearchClinical Trial Phase ICombination ChemotherapyDietary SupplementsDiureticsDosageDrug Screening /EvaluationHuman SubjectHypertensionIga NephropathyKidney FunctionMarine Animal OilMiddle Childhood (6-11)Nutrition Related TagPrednisoneYoung Adult Human (21-34)Antihypertensive Agents
Grant awards (6)
NORTH AMERICAN IGA NEPHROPHATHY STUDY$0
M01 · FY2002 · RR
TRIAL OF ZIAC (BISOPROLOL FUMARATE HYDROCHLOROTHIAZIDE) IN HYPERTENSION$0
M01 · FY2002 · RR
NORTH AMERICAN IGA NEPHROPHATHY STUDY$0
M01 · FY2001 · RR
TRIAL OF ZIAC (BISOPROLOL FUMARATE HYDROCHLOROTHIAZIDE) IN HYPERTENSION$0
M01 · FY2001 · RR
NORTH AMERICAN IGA NEPHROPHATHY STUDY$22,028
M01 · FY2000 · RR
TRIAL OF ZIAC (BISOPROLOL FUMARATE HYDROCHLOROTHIAZIDE) IN HYPERTENSION$0
M01 · FY2000 · RR